NIMHD Notice of Funding Opportunity Announcements (NOFOAs) include Requests for Applications (RFAs), Program Announcements (PAs/PARs), and Notice's of Changes and Guidelines (NOTs). This page highlights open funding opportunities with upcoming expiration dates.
-
Accelerating Behavioral and Social Science Through Ontology Development and Use: Research Network Projects (U01 Clinical Trial Not Allowed) (PAR-23-182)
-
Identifying Innovative Mechanisms or Interventions that Target Multimorbidity and Its Consequences (R01 Clinical Trial Optional) (PAR-20-180)
-
STrengthening Research Opportunities for NIH Grants (STRONG): Structured Institutional Needs Assessment and Action Plan Development for Resource Limited Institutions (RLIs) (UC2 Clinical Trial Not Allowed) (PAR-23-144)
-
Time-Sensitive Opportunities for Health Research (R61/33 Clinical Trial Not Allowed) (PAR-22-233)
-
Tobacco Control Policies to Promote Health Equity (R01 Clinical Trial Optional) (PAR-20-302)
-
Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) (PAR-20-238)
-
Research to Improve Native American Health (R21 Clinical Trials Optional) (PAR-20-214)
-
Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) (PAR-20-254)
-
Identifying Innovative Mechanisms or Interventions that Target Multimorbidity and Its Consequences (R01 Clinical Trial Optional) (PAR-20-180)
-
Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional) (PA-20-172)
-
NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional) (PAR-20-150)
-
NIMHD Centers of Excellence in Investigator Development and Community Engagement (P50 Clinical Trial Optional) (RFA-MD-23-011)
-
Emergency Award: RADx-UP Dissemination and Implementation (D&I) Research on COVID-19 Testing Interventions Among Underserved and Vulnerable Populations (R01 Clinical Trial Optional) (RFA-OD-23-050)
-
Emergency Award: Novel Insights Through Cross-Site Analyses of Existing RADx-UP Data (R21 Clinical Trial Not Allowed) (RFA-OD-23-050)
-
Community-Level Interventions to Improve Minority Health and Reduce Health Disparities (R01 Clinical Trial Optional) (RFA-MD-23-004)
-
Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 Clinical Trial Optional) (RFA-MD-23-003)
-
Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42 Clinical Trial Optional) (RFA-MD-23-002)
-
Galvanizing Health Equity Through Novel and Diverse Educational Resources (GENDER) Research Education (R25 Clinical Trial Not Allowed) (RFA-OD-22-015)
Visit this page to view a full list of all active NIMHD funding opportunities and their details.